262 results on '"Di Ianni, Mauro"'
Search Results
2. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?
3. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
4. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
5. Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses
6. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
7. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
8. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.
9. Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.
10. Myelofibrosis and allogeneic transplantation: critical points and challenges.
11. Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation
12. Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis
13. Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
14. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
15. Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma
16. Clinical-Grade–Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell–Dependent Graft-versus-Leukemia Effect in Murine Models
17. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation.
18. Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation
19. CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy
20. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
21. Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)
22. “Designed” grafts for HLA-haploidentical stem cell transplantation
23. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
24. Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines.
25. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity
26. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice
27. Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL
28. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
29. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
30. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35
31. NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
32. A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia
33. Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
34. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice
35. Interleukin-7–Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population
36. T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection
37. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study
38. A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia
39. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
40. Tregs combined with mature donor T cells hasten immune reconstitution without triggering GvHD in HLA haploidentical transplantation
41. Adoptive Immunotherapy with Regulatory and Conventional T Cells in Haploidentical Transplantation Primes Dendritic Cells to Promote T Cell Alloreactivity in the Bone Marrow and Tolerance in the Periphery
42. Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation
43. 220 - DONOR Lymphocyte Infusions after Haploidentical STEM Cell Transplantation with Ptcy: A Study on Behalf of the Ctiwp of the EBMT
44. Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience
45. How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation
46. NOTCH and Graft-Versus-Host Disease
47. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
48. NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells
49. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
50. How the Real-Life Diagnostic and Therapeutic Approach Changed in the Last Two Decades in the Thrombocythemic Patients with Ph- Negative Myeloproliferative Neoplasm. Report on 2388 Subjects of the Registro Italiano Trombocitemie (RIT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.